Meet Our Team
Our Advisory Board Brings Expertise and Insight
We leverage their experience to drive innovation forward.
Maria
Chen
Lopez
Consultant
Advisor
Mrs.
Mr.
Fatima
Our Focus
Collaborative Approach
VaxFarm drives scientific innovation through collaboration with universities, industry partners, and health experts, turning cutting-edge research into safe, scalable, and impactful vaccines.
Dedicated to Vaccine Solutions
Impactful Research
Explore our unique methodologies and state-of-the-art facilities. VaxFarm leverages advanced instrumentation and modern technologies to meet the evolving demands of future vaccine development.
Turning Science into Solutions
Using AI & cutting edge technologies to drive innovation
Using AI and cutting-edge technologies, VaxFarm designs and develops next-generation vaccine targets to accelerate scientific innovation and global health impact.
Guiding Innovation Forward
Our team is dedicated to groundbreaking scientific advancements.
VaxFarm™ has invested more than 7 years to build a portfolio of novel and traditional vaccines with improved thermostability assets rooted in strong mechanistic science. Today, that focus is delivering results, with multiple programs advancing toward 12–24-month catalysts that have the potential to create meaningful impact for patients and value for stakeholders.
Anurag Gupta, PhD
Founder
Sachin Gupta, PhD
Director - Business Operations
Anurag brings over 21 years of experience and plays a pivotal role in advancing the company’s portfolio and platform strategy. He is a Process Development Scientist specializing in novel VLP-based vaccine technologies, as well as live attenuated and inactivated vaccines with enhanced thermostability.
He has been directly involved in the development of multiple vaccines, including Recombinant HEV, Chikungunya, H1N1, and Seasonal Influenza vaccines, and notably India’s first Dengue vaccine, which is currently in clinical development. Anurag has successfully bridged R&D and GMP manufacturing, ensuring smooth process transfer and scale-up in regulated environments.
He has previously worked with leading Indian pharmaceutical companies such as Torrent, Ranbaxy, and Panacea Biotec, and holds a Ph.D. in Biotechnology.
Dr Gupta is a Pharmacist and Biomedical Research Scientist with strong expertise in translational medicine and immunology. He completed his PhD in Medicine focusing on Asthma and Viral Immunology at The University of Newcastle, Australia.
Prior to joining VaxFarm, Dr Gupta worked as a Research Scientist at the Institute of Haematology, Royal Prince Alfred Hospital, Sydney, within NSW Health, where he contributed to hospital-based and laboratory research programs in immunotherapy, including CAR-T cell therapy for lymphomas and multiple myeloma.
He also brings a strong foundation in pharmacology, toxicology, and immunology research, with a demonstrated ability to bridge laboratory science with patient-focused clinical research.